Literature DB >> 150690

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).

J Ludwig, E R Dickson, G S McDonald.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 150690     DOI： 10.1007/bf00432479

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN： 0340-1227


× No keyword cloud information.
  7 in total

1.  PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.

Authors:  E RUBIN; F SCHAFFNER; H POPPER
Journal:  Am J Pathol       Date:  1965-03       Impact factor: 4.307

2.  The problem of primary biliary cirrhosis.

Authors:  H POPPER; E RUBIN; F SCHAFFNER
Journal:  Am J Med       Date:  1962-12       Impact factor: 4.965

3.  Localization of the basic injury in primary biliary cirrhosis.

Authors:  E RUBIN; F SCHAFFNER; H POPPER
Journal:  JAMA       Date:  1963-02-02       Impact factor: 56.272

Review 4.  A review of lobular, portal, and periportal hepatitis. Interpretation of biopsy specimens without clinical data.

Authors:  J Ludwig
Journal:  Hum Pathol       Date:  1977-05       Impact factor: 3.466

Review 5.  Nonsuppurative destructive chronic cholangitis and chronic hepatitis.

Authors:  H Popper; F Schaffner
Journal:  Prog Liver Dis       Date:  1970

6.  Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper.

Authors:  R R Lindquist
Journal:  Arch Pathol       Date:  1969-04

7.  Primary biliary cirrhosis.

Authors:  P Scheuer
Journal:  Proc R Soc Med       Date:  1967-12
  7 in total
  128 in total

1.  Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment.

Authors:  M Leuschner; C F Dietrich; T You; C Seidl; J Raedle; G Herrmann; H Ackermann; U Leuschner
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis.

Authors:  Burton Combes; Velimir A Luketic; Marion G Peters; Rowen K Zetterman; Guadalupe Garcia-Tsao; Santiago J Munoz; Danyu Lin; Nancy Flye; Robert L Carithers
Journal:  Am J Gastroenterol       Date:  2004-02       Impact factor: 10.864

3.  The immunopathology of liver granulomas in primary biliary cirrhosis.

Authors:  Zhengrui You; Qixia Wang; Zhaolian Bian; Yuan Liu; Xiaofeng Han; Yanshen Peng; Lei Shen; Xiaoyu Chen; Dekai Qiu; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  J Autoimmun       Date:  2012-06-23       Impact factor: 7.094

Review 4.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 5.  Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.

Authors:  Nicola Bizzaro; Giovanni Covini; Floriano Rosina; Paolo Muratori; Elio Tonutti; Danilo Villalta; Fiorenza Pesente; Maria Grazia Alessio; Marilina Tampoia; Antonio Antico; Stefan Platzgummer; Brunetta Porcelli; Lucia Terzuoli; Marco Liguori; Danila Bassetti; Ignazio Brusca; Piero L Almasio; Giuseppe Tarantino; Chiara Bonaguri; Paolo Agostinis; Elena Bredi; Renato Tozzoli; Pietro Invernizzi; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

6.  Histologic features of steatohepatitis in patients with a clinical diagnosis of autoimmune cholestasis.

Authors:  Diego Sánchez-Muñoz; Victor M Castellano-Megías; Manuel Romero-Gómez
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

7.  Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.

Authors:  E I Rigopoulou; E T Davies; A Pares; K Zachou; C Liaskos; D-P Bogdanos; J Rodes; G N Dalekos; D Vergani
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

8.  Two different types of antimitochondrial antibodies (anti-M2 and anti-M4) may not differentiate primary biliary cirrhosis (PBC) with prominent piecemeal necrosis from classical PBC.

Authors:  T Okuno; M Shindo; M Matsumoto; K Arai; M Takeda; M Iwai; T Nakashima; T Takino
Journal:  Gastroenterol Jpn       Date:  1989-02

9.  Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

Authors:  R A Jorgensen; E R Dickson; A F Hofmann; S S Rossi; K D Lindor
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

10.  Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment.

Authors:  Meri Koulentaki; Joanna Moscandrea; Philipos Dimoulios; Costas Chatzicostas; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.